MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis

Proceedings of the National Academy of Sciences of the United States of America

Volumn 105, Issue 35, 2008, Pages 12885-12890

  Pichiorri, Flavia ^a   Suh, Sung Suk ^a   Ladetto, Marco ^b   Kuehl, Michael ^c   Palumbo, Tiziana ^a   Drandi, Daniela ^b   Taccioli, Cristian ^a   Zanesi, Nicola ^a   Alder, Hansjuerg ^a   Hagan, John P ^a   Munker, Reinhold ^d   Volinia, Stefano ^a   Boccadoro, Mario ^b   Garzon, Ramiro ^a   Palumbo, Antonio ^b   Aqeilan, Rami I ^a,e   Croce, Carlo M ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF TURIN   (Italy)

^c NATIONAL CANCER INSTITUTE   (United States)

^d Louisiana State University School of Medicine Shreveport   (United States)

^e HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

MGUS; PCAF; Plasma cells; SOCS 1; Tumor suppressor gene

Indexed keywords

HISTONE ACETYLTRANSFERASE PCAF; MICRORNA; PROTEIN P53;

ARTICLE; BONE MARROW CELL; COMPARATIVE STUDY; CONTROLLED STUDY; DOWN REGULATION; GENE CLUSTER; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; MONOCLONAL IMMUNOGLOBULINEMIA; MULTIPLE MYELOMA; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION;

ANIMALS; APOPTOSIS REGULATORY PROTEINS; BASE SEQUENCE; CELL LINE, TUMOR; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, NEOPLASM; HEALTH; HUMANS; MEMBRANE PROTEINS; MICE; MICE, NUDE; MICRORNAS; MOLECULAR SEQUENCE DATA; MONOCLONAL GAMMOPATHIES, BENIGN; MULTIPLE MYELOMA; P300-CBP TRANSCRIPTION FACTORS; PLASMA CELLS; PROTO-ONCOGENE PROTEINS; RECEPTORS, INTERLEUKIN-6; REPRESSOR PROTEINS; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STAT3 TRANSCRIPTION FACTOR; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION;

MUS MUSCULUS;

EID: 51349093465     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0806202105     Document Type: Article

References (37)

1. Bommert K, Bargou R, Stühmer T (2006) Signalling and survival pathways in multiple myeloma. Eur J Cancer 42:1574-1580.
2. Fonseca R, San Miguel J (2007) Prognostic factors and staging in multiple myeloma. Hematol Oncol Clin N Am 21:1115-1140.
3. Hideshima T, Mitsiades C, Tono G, Richardson PG, Anderson KC (2007) Understanding multiple myeloma pathogenesis in the bone marrow to identify new therapeutic targets. Nat Rev Cancer 7:585-598.
4. Oancea M, Mani A, Hussein MA, Almasan A (2004) Apoptosis of multiple myeloma. Int J Hematol 80:224-231.
5. Drach J, et al. (1995) Multiple myeloma: High incidence of chromosomal aneuploidy as detected by interphase fluorescence in situ hybridization. Cancer Res 55:3854-3859.
6. Latreille J, Barlogie B, Johnston D, Drewinko B, Alexanian R (1982) Ploidy and proliferative characteristics in monoclonal gammopathies. Blood 59:43-51.
7. Chng WJ, Glebov O, Bergsagel PL, Kuehl WM (2007) Genetic events in the pathogenesis of multiple myeloma. Best Pract Res Clin Haematol 20:571-596.
8. Calin GA, et al. (2005) A microRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med 353:1793-1801.
9. Garzon R, et al. (2008) MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia. Blood 111:3183-3189.
10. Bartel D (2004) MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 116:281-297.
11. Croce CM (2008) Oncogenes and cancer. N Engl J Med 358:502-511.
12. Garzon R, et al. (2007) MicroRNA gene expression during retinoic acid-induced differentiation of human acute promyelocytic leukemia. Oncogene 26:4148-4157.
13. Calin GA, Croce CM (2006) MicroRNA signatures in human cancers. Nat Rev Cancer 6:857-866.
14. Löffler D, et al. (2007) Interleukin-6 dependent survival of multiple myeloma cells involves the Stat3-mediated induction of microRNA-21 through a highly conserved enhancer. Blood 110:1330-1333.
15. Seidl S, Kaufmann H, Drach J (2003) New insights into the pathophysiology of multiple myeloma. Lancet Oncol 4:557-564.
16. Chen CZ, Li L, Lodish HF, Bartel DP (2004) MicroRNAs modulate hematopoietic lineage differentiation. Science 303:83-86.
17. Liu CG, Calin GA, Volinia S, Croce CM (2008) MicroRNA expression profiling using microarrays. Nat Protoc 3:563-578.
18. He L, et al. (2005) A microRNA polycistron as a potential human oncogene. Nature 435:828-833.
19. Ventura A, et al. (2008) Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 families of miRNA clusters. Cell 132:875-886.
20. Petrocca F, et al. (2008) E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer. Cancer Cell 13:272-286.
21. Lewis B, Shih I, Jones-Rhoades M, Bartel D, Burge C (2003) Prediction of mammalian microRNA targets. Cell 115:787-798.
22. Krek A, et al. (2005) Combinatorial microRNA target prediction. Nat Genet 37:495-500.
23. Schiltz RL, Nakatani Y (2000) The PCAF acetylase complex as a potential tumor suppressor. Biochim Biophys Acta 1470:M37-M53.
24. Linares LK, et al. (2007) Intrinsic ubiquitination activity of PCAF controls the stability of the oncoprotein Hdm2. Nat Cell Biol 9:331-338.
25. Imamura J, Miyoshi I, Koeffler HP (1994) p53 in hematologic malignancies. Blood 84:2412-2421.
26. Stühmer T, Bargou RC (2005) Selective pharmacologic activation of the p53-dependent pathway as a therapeutic strategy for hematologic malignancies. Cell Cycle 5:39-42.
27. Greenhalgh CJ, Hilton DJ (2001) Negative regulation of cytokine signaling. J Leukoc Biol 70:348-356.
28. Galm O, Yoshikawa H, Esteller M, Osieka R, Herman JG (2002) SOCS-1, a negative regulator of cytokine signaling, is frequently silenced by methylation in multiple myeloma. Blood 101:2784-2788.
29. Schwab G, Siegall CB, Aarden LA, Neckers LM, Nordan RP (1991) Characterization of an interleukin-6-mediated autocrine growth loop in the human multiple myeloma cell line, U266. Blood 77:587-593.
30. Volinia S, et al. (2006) AmicroRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 103:2257-2261.
31. Garzon R, et al. (2008) Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin. Proc Natl Acad Sci USA 105:3945-3950.
32. Zhan F, et al. (2002) Global gene expression profiling of multiple myeloma, monoclonal gammopathy of undetermined significance, and normal bone marrow plasma cells. Blood, 99:1745-1757.
33. Chan JA, Krichevsky AM, Kosik KS (2005) MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 65:6029-6033.
34. Meng F, et al. (2007) MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 133:647-658.
35. Novotny GW, et al. (2007) Translational repression of E2F1 mRNA in carcinoma in situ and normal testis correlates with expression of the miR-17-92 cluster. Cell Death Differ 14:879-882.
36. O'Donnell KA, Wentzel EA, Zeller KI, Dang CV, Mendell JT (2005) c-Myc-regulated microRNAs modulate E2F1 expression. Nature 435:839-843.
37. Liu CG, et al. (2004) An oligonucleotide microchip for genomic-wide microRNA profiling in human and mouse tissues. Proc Natl Acad Sci USA 101:9740-9744.